IBI Group Inc (IBG.CA)       19.48  -0.01 (-0.05%)

19.48  -0.01 (-0.05%)

CA44925L1031 - Common Stock


Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to IBG. IBG was compared to 72 industry peers in the Professional Services industry. Both the profitability and the financial health of IBG get a neutral evaluation. Nothing too spectacular is happening here. IBG is valued quite expensive, but it does show an excellent growth.




Profitability

Profitability Rating

4

IBG's Return On Equity of 28.61% is amongst the best of the industry. IBG does better than the industry average Return On Equity of 18.13%.
The Piotroski-F score of IBG is 7.00. This is a strong score and indicates good health and profitability for IBG.

IBG has a Return On Assets of 6.63%. This is comparable to the industry average of 7.25%.
IBG has a Profit Margin of 5.28%. This is below the industry average of 7.12%.
VS Industry

ROA (6.63%) VS Industry: 43% outperformed.

0.35
46.57

ROE (28.61%) VS Industry: 77% outperformed.

0.52
249.31

Profit Margin (5.28%) VS Industry: 38% outperformed.

0.19
37.19

Valuation

Valuation Rating

3

IBG's low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
When comparing the Enterprise Value to EBITDA ratio of IBG to the average industry ratio of 12.81, IBG is valued rather cheaply.
The Price/Earnings Ratio is 24.97, which indicates a rather expensive current valuation of IBG.
With a Forward Price/Earnings Ratio of 20.27, IBG is valued rather expensively.

When comparing the current price to the book value of IBG, we can conclude it is valued correctly. It is trading at 7.02 times its book value.
IBG's Price/Earning Ratio is slightly more expensive than the industry average, which is at 17.10.
Compared to an average industry price book ratio of 2.53, IBG is valued more expensive than its industry peers. 85% of the companies listed in the same industry are valued cheaper.
VS Industry

Price/Earnings (24.97) VS Industry: 28% outperformed.

1,203.50
2.35

Price/Book (7.02) VS Industry: 15% outperformed.

71.01
0.06

Enterprise Value/ EBITDA (9.36) VS Industry: 66% outperformed.

54.14
0.12

Growth

Growth Rating

7

IBG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 56.00%, which is quite impressive.
IBG shows a strong growth in Earnings Per Share. Measured over the last 5 years, the EPS has been growing by 75.18% yearly.
Based on estimates for the next 5 years, IBG will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.01% on average per year.
The Revenue has grown by 12.12% in the past year. This is quite good.

When comparing the Revenue growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
Measured over the past 5 years, IBG shows a small growth in Revenue. The Revenue has been growing by 4.65% on average per year.
The Revenue is expected to grow by 6.60% on average over the next 5 years.
The EPS growth is decreasing: in the next 5 years the growth will be less than in the last years.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS75.18% 15.35% 56% 30.59% 20.68% 18.7% 18.01%
Revenue4.65% 6.47% 12.12% 8.97% 6.86% 6.51% 6.6%

Health

Health Rating

4

When comparing the Current Ratio to an average industry Current Ratio of 1.45, IBG is better placed than the average industry peer to meet its short term obligations.
The Quick Ratio of IBG is much better than the industry average of 1.45.
IBG has a good Piotroski-F score of 7.00. This indicates a good health and good profitability for IBG.
IBG has a Current Ratio of 1.79. This is a normal value and indicates that IBG is financially healthy and should not expect problems in meeting its short term obligations.

IBG has a Quick Ratio of 1.79. This is a normal value and indicates that IBG is financially healthy and should not expect problems in meeting its short term obligations.
IBG has an Altman-Z score of 2.59. This is not the best score and indicates that IBG is in the grey zone with still only limited risk for bankruptcy at the moment.
IBG has one of the worst Debt to Equity ratios in its industry. 88% of its industry peers require less debt for financing their operations.
When comparing the Altman-Z score of IBG to the average industry Altman-Z score of 3.09, IBG is less financially healthy than its industry peers.
VS Industry

Debt/Equity (1.25) VS Industry: 12% outperformed.

6.11
0.00

Quick Ratio (1.79) VS Industry: 62% outperformed.

0.30
15.36

Current Ratio (1.79) VS Industry: 62% outperformed.

0.30
15.36

Altman-Z (2.59) VS Industry: 40% outperformed.

-47.12
44.80

Dividend

Dividend Rating

0

IBG does not give a dividend.

IBI Group Inc19.48

TSX:IBG (9/28/2022, 6:00:00 PM)-0.01 (-0.05%)

Chartmill FA Rating
GICS Sector Industrials
GICS IndustryGroup Commercial & Professional Services
GICS Industry Professional Services
Earnings (Last) N/A N/A Earnings (Next) N/A N/A
Inst Owners 18.08% Inst Owner Change N/A
Ins Owners N/A Ins Owner Change N/A
Market Cap 607.99M Analysts 80
Price Target 19.76 (1.44%)

Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y) N/A DP 0%
Div Incr Years N/A Div Non Decr Years N/A
Ex-Date N/A

Surprises & Revisions
EPS beat(2) N/A Avg EPS beat(2) N/A
Min EPS beat(2) N/A Max EPS beat(2) N/A
EPS beat(4) N/A Avg EPS beat(4) N/A
Min EPS beat(4) N/A Max EPS beat(4) N/A
Revenue beat(2) N/A Avg Revenue beat(2) N/A
Min Revenue beat(2) N/A Max Revenue beat(2) N/A
Revenue beat(4) N/A Avg Revenue beat(4) N/A
Min Revenue beat(4) N/A Max Revenue beat(4) N/A
PT rev (1m) N/A PT rev (3m) N/A
EPS NQ rev (1m) N/A EPS NQ rev (3m) N/A
EPS NY rev (1m) N/A EPS NY rev (3m) N/A
Revenue NQ rev (1m) N/A Revenue NQ rev (3m) N/A
Revenue NY rev (1m) N/A Revenue NY rev (3m) N/A

Valuation
Industry RankSector Rank
PE 24.97
Fwd PE 20.27
P/S 1.3
P/FCF N/A
P/OCF N/A
P/B 7.02
P/tB N/A
EV/EBITDA 9.36
EPS(TTM) 0.78 EY 4%
EPS(NY) 0.96 Fwd EY 4.93%
FCF(TTM) N/A FCFY N/A
OCF(TTM) N/A OCFY N/A
SpS 15.04 BVpS 2.78
TBVpS N/A PEG (NY) 0.82
PEG (5Y) 0.33

Profitability
Industry RankSector Rank
ROA 6.63%
ROE 28.61%
ROIC 16.53%
ROICexc N/A
ROICexgc 19.26%
OM N/A
PM 5.28%
GM N/A
ROICexgc(3y) N/A ROICexcg growth 3Y 0%
ROICexcg growth 5Y 0% ROICexc(3y) N/A
ROICexc growth 3Y N/A ROICexc growth 5Y N/A
OM growth 3Y N/A OM growth 5Y N/A
PM growth 3Y N/A PM growth 5Y N/A
GM growth 3Y N/A GM growth 5Y N/A
F-Score 7 Asset Turnover 1.26

Health
Industry RankSector Rank
Debt/Equity 1.25
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Profit Quality N/A
Current Ratio 1.79
Quick Ratio 1.79
Altman-Z 2.59
F-Score 7 WACC 6.91%
ROIC/WACC 2.79 Cap/Depr(3y) N/A
Cap/Depr(5y) N/A Profit Quality(3y) N/A
Profit Quality(5y) N/A

Growth
EPS 1Y 56% EPS 3Y 15.35%
EPS 5Y 75.18% EPS growth Q2Q 9.09%
EPS Next Y 30.59% EPS Next 2Y 20.68%
EPS Next 3Y 18.7% EPS Next 5Y 18.01%
Revenue growth 1Y 12.12% Revenue growth 3Y 6.47%
Revenue growth 5Y 4.65% Revenue growth Q2Q 11.59%
Revenue Next Year 8.97% Revenue Next 2Y 6.86%
Revenue Next 3Y 6.51% Revenue Next 5Y 6.6%
EBIT growth 1Y N/A EBIT growth 3Y N/A
EBIT growth 5Y N/A EBIT Next Year N/A
EBIT Next 3Y N/A EBIT Next 5Y N/A
FCF growth 1Y N/A FCF growth 3Y N/A
FCF growth 5Y N/A OCF growth 1Y N/A
OCF growth 3Y N/A OCF growth 5Y N/A

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the Canadian

Screen Image

Growth Stock Screener

Find more growth stocks the Canadian

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the Canadian

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the Canadian

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the Canadian